We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Accelsius and AeroFlexx started generating revenue with expectations to grow in 2025Founded fourth company, Refinity, to commercialize ...

For the quarter, the Voya Global Advantage and Premium Opportunity Fund provided a total return of 0.36% on a net asset value ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

The federal government is increasing their 2026 Medicare subsidy payments, a lot, because of the health cost surge.

With a market cap of $102.5 billion, Elevance Health, Inc. (ELV) is a health benefits company offering a wide range of ...

Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth ...

Harrow Health demonstrated robust performance in Q4 2024, marked by significant revenue growth and strong product sales. The company capitalized on its innovative product offerings and strategic ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here. In the fourth ...

P3 Health Partners Inc Good day and welcome to the P3 Health Partners fourth-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like ...